The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests [0.03%]
适用于评估多种筛查技术的有效存储样本设计：在多癌症检测中的应用
Stuart G Baker,Hormuzd A Katki
Stuart G Baker
ObjectiveMulticancer detection (MCD) tests use blood specimens to screen for various cancers with the hope of reducing cancer mortality. Various companies are developing MCD tests, each with a different technology. For evaluating k MCD test...
Poisson regression with adjustment for contamination and non-compliance in cohort studies conducted to estimate intervention effectiveness [0.03%]
校正污染和未依从性的队列研究中干预效果估计的泊松回归分析方法研究
Håkan Jonsson,Lennarth Nyström,Johannes Blom
Håkan Jonsson
BackgroundThe effectiveness of an intervention such as cancer screening can be estimated by conducting a cohort study estimating the rate ratio between an exposed group invited to screening and a control group not invited to screening. A co...
Response to 'Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change' [0.03%]
"六周产后宫颈癌筛查：从可接受性走向机制证据和政策变革的回答"
Victoria Cullimore,Rebecca Newhouse,Holly Baker-Rand et al.
Victoria Cullimore et al.
Cancer screening after the age of 75: Nationwide population-based trends [0.03%]
75岁以上人群癌症筛查的全国人口统计趋势分析
Frerik Smit,Axelle Braggion,Stéphane Cullati et al.
Frerik Smit et al.
ObjectivesCancer screening among older adults above 75 years of age is frequent despite generally not being recommended in evidence-based guidelines. We aimed to describe trends in prostate, cervical, breast, and colorectal cancer screening...
Six-week postnatal cervical screening: Moving from acceptability toward mechanistic evidence and policy change [0.03%]
产后六周宫颈筛查：从可接受性走向机制证据和政策改变
Chutharat Thanchonnang,Schawanya K Rattanapitoon,Nav La et al.
Chutharat Thanchonnang et al.
Cancer history and cardiovascular diseases: Implications for colorectal and breast cancer screening [0.03%]
癌症史与心血管疾病：结直肠癌和乳腺癌筛查的启示
Elinita Pollard,Avirup Guha,Ryan A Harris et al.
Elinita Pollard et al.
PurposeCancer survivors and those with cardiovascular diseases have an increased risk of developing colorectal cancer and breast cancer. Undergoing colorectal cancer screening and mammogram uptake within the recommended intervals have the p...
Comments on "Effects of COVID-19 pandemic on breast cancer screening" by Huang et al. https://doi.org/10.1177/09691413251338456 [0.03%]
关于黄等人发表的“COVID-19大流行对乳腺癌筛查的影响”的评论原文引用：https://doi.org/10.1177/09691413251338456
Kathie Binysh,Stephen W Duffy
Kathie Binysh
Assessment of the value of polygenic risk scores in the prevention of disease [0.03%]
评估多基因风险评分在疾病预防方面的价值
Aroon D Hingorani
Aroon D Hingorani
It is claimed that polygenic risk scores will transform disease prevention, but a typical polygenic risk score for a common disease only detects 11% of affected individuals at a 5% false positive rate. This level of screening performance is...
An economic scenario analysis of implementing artificial intelligence in BreastScreen Norway-Impact on radiologist person-years, costs and effects [0.03%]
在乳腺筛查中实施人工智能的经济情景分析-对放射科医生人年、成本和效果的影响
Tron Anders Moger,Sahand Barati Nardin,Åsne Sørlien Holen et al.
Tron Anders Moger et al.
ObjectiveTo study the implications of implementing artificial intelligence (AI) as a decision support tool in the Norwegian breast cancer screening program concerning cost-effectiveness and time savings for radiologists.MethodsIn a decision...
Variation in fecal hemoglobin concentrations: Cross-sectional analysis of a screening trial and a screening program in Sweden [0.03%]
粪便血红蛋白浓度的变异：瑞典一项筛查试验和一个筛查项目中的横断面分析
Masau Sekiguchi,Christian Löwbeer,Robert Steele et al.
Masau Sekiguchi et al.
ObjectivesTo assess variation in fecal hemoglobin concentration according to year and season of fecal immunochemical test screening in Sweden, the detection rate of advanced neoplasia, and factors that could influence fecal immunochemical t...